{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:46:39Z","timestamp":1790930799486,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.dld.2010.05.019","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T08:41:31Z","timestamp":1278578491000},"page":"757-764","source":"Crossref","is-referenced-by-count":20,"title":["Current topics in autoimmune hepatitis"],"prefix":"10.1016","volume":"42","author":[{"given":"Luigi","family":"Muratori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Granito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgios","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2010.05.019_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2010.05.019_bib0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0030","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0029-1233532","article-title":"Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future","volume":"29","author":"Wiegard","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.dld.2009.06.013","article-title":"Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","article-title":"Review article: the modern management of autoimmune hepatitis","volume":"31","author":"Yeoman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.05.019_bib0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0065","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jhep.2005.06.006","article-title":"Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis","volume":"43","author":"Miyake","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0070","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2005.11.050","article-title":"In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?","volume":"44","author":"Verma","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1572-0241.2007.01147.x","article-title":"Remission in autoimmune hepatitis: what is it, and can it ever be achieved?","volume":"102","author":"Al-Chalabi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0085","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology, in press."},{"key":"10.1016\/j.dld.2010.05.019_bib0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1440-1827.2010.02515.x","article-title":"Assessment of hepatic fibrosis by transient elastography in patients with chronic hepatitis B","volume":"60","author":"Zhang","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MEG.0b013e328332dd0a","article-title":"Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy","volume":"22","author":"Anastasiou","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00535-008-2225-2","article-title":"Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases","volume":"43","author":"Obara","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0110","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1478-3231.2008.01743.x","article-title":"Disproportionally high results of transient elastography in patients with autoimmune hepatitis","volume":"28","author":"Romanque","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1089-3261(02)00027-2","article-title":"New autoantibodies and autoantigens in autoimmune hepatitis","volume":"6","author":"Bianchi","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0130","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.05.019_bib0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.dld.2010.05.019_bib0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.05.019_bib0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux-Henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.05.019_bib0160","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","author":"Muratori","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/eji.200323857","article-title":"Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis","volume":"33","author":"Lapierre","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0170","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2003.11.001","article-title":"Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection","volume":"22","author":"Beland","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2010.05.019_bib0180","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.05.019_bib0185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0195","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA\u2013protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2010.05.019_bib0200","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930410001686260","article-title":"Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection","volume":"37","author":"Vitozzi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2010.05.019_bib0220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2010.05.019_bib0225","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2010.05.019_bib0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2010.05.019_bib0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.05.019_bib0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2010.05.019_bib0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2010.05.019_bib0250","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005176-200102000-00007","article-title":"Autoimmune hepatitis as a late complication of liver transplantation","volume":"32","author":"Hernandez","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2010.05.019_bib0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2010.05.019_bib0265","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0041-1345(03)00059-9","article-title":"Antibodies against glutathione S-transferase T1 in patients with immune hepatitis after liver transplantation","volume":"35","author":"Aguilera","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2010.05.019_bib0270","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation","volume":"10","author":"Aguilera","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2010.05.019_bib0275","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/j.transproceed.2005.10.042","article-title":"Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation","volume":"37","author":"Aguilera","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2010.05.019_bib0280","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation","volume":"15","author":"Salcedo","year":"2009","journal-title":"Liver Transpl"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2010.05.019_bib0285","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S0168-8278(10)60491-6","article-title":"Clinical impact and behaviour of serum autoantibodies in adult liver transplantation","volume":"52","author":"Granito","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0290","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0300","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2010.05.019_bib0305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2010.05.019_bib0310","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0315","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0320","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0325","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2008-1042650","article-title":"Evolution from primary biliary cirrhosis to primary biliary cirrhosis\/autoimmune hepatitis overlap syndrome","volume":"28","author":"Twaddell","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0335","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ajg.2009.602","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"105","author":"Efe","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0345","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0350","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0355","first-page":"221","article-title":"Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study","volume":"55","author":"Mishima","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2010.05.019_bib0360","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0365","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0370","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0b013e31802dbdfc","article-title":"Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background","volume":"42","author":"Bittencourt","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0375","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0380","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0385","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0390","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0395","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.05.019_bib0400","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","article-title":"Current and future treatments of autoimmune hepatitis","volume":"3","author":"Czaja","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0405","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis\u2014report of three cases","volume":"35","author":"Kanzler","year":"1997","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0410","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0415","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2010.05.019_bib0420","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1478-3231.2006.01262.x","article-title":"Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature","volume":"26","author":"Santos","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0425","first-page":"13","article-title":"Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis","volume":"10","author":"Carmassi","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0430","first-page":"630","article-title":"Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis","volume":"91","author":"Rebollo Bernardez","year":"1999","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.dld.2010.05.019_bib0435","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0440","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12072-009-9155-9","article-title":"Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis","volume":"3","author":"Miyake","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0445","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2036.2005.02581.x","article-title":"On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment","volume":"22","author":"de Boer","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.05.019_bib0450","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00042737-200504000-00012","article-title":"Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine","volume":"17","author":"de Boer","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0455","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0460","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0465","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow-up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","author":"Cuarterolo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2010.05.019_bib0470","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.2003.01754.x","article-title":"Effectiveness and safety of cyclosporine as therapy for autoimmune diseases of the liver in children and adolescents","volume":"19","author":"Sciveres","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.05.019_bib0475","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1399-3062.2009.00407.x","article-title":"Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity","volume":"11","author":"Ritter","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0480","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0485","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0490","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0495","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian Association for the Study of Liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0500","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0505","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0510","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","article-title":"Mycophenolate mofetil for autoimmune hepatitis: a single practice experience","volume":"54","author":"Wolf","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2010.05.019_bib0515","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0520","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2165\/00003495-199550050-00006","article-title":"A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease","volume":"50","author":"Spencer","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2010.05.019_bib0525","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2165\/00003495-200262150-00015","article-title":"Budesonide (Entocort EC Capsules): a review of its therapeutic use in the management of active Crohn's disease in adults","volume":"62","author":"McKeage","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2010.05.019_bib0530","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000296.pub3","article-title":"Budesonide for induction of remission in Crohn's disease","author":"Seow","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2010.05.019_bib0535","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic active hepatitis","volume":"8","author":"Danielsson","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.05.019_bib0540","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.05.019_bib0545","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","article-title":"Budesonide in previously untreated autoimmune hepatitis","volume":"25","author":"Wiegand","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2010.05.019_bib0550","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","author":"Geier","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0555","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","article-title":"Budesonide induces complete remission in autoimmune hepatitis","volume":"12","author":"Csepregi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0560","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1155\/2008\/509459","article-title":"The use of budesonide in the treatment of autoimmune hepatitis in Canada","volume":"22","author":"Zandieh","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2010.05.019_bib0565","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0168-8278(08)60991-5","article-title":"Budesonide 3mg tid is superior to prednisone in combination with azathioprine in the treatment of autoimmune hepatitis","volume":"48","author":"Manns","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0570","first-page":"376A","article-title":"Budesonide 3mg bid in combination with azathioprine as maintenance treatment of autoimmune hepatitis\u2014final results of a large multicenter international trial","volume":"48","author":"Manns","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0575","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0580","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.smim.2003.12.003","article-title":"Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance","volume":"16","author":"Piccirillo","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0585","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cyto.2008.07.469","article-title":"Regulatory T cells in health and disease","volume":"43","author":"Piccirillo","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.dld.2010.05.019_bib0590","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.coi.2008.09.006","article-title":"CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas","volume":"20","author":"Piccirillo","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0595","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2010.05.019_bib0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2010.05.019_bib0605","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2010.05.019_bib0610","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0615","unstructured":"Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T-cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology, in press."},{"key":"10.1016\/j.dld.2010.05.019_bib0620","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0029-1233536","article-title":"New animal models for autoimmune hepatitis","volume":"29","author":"Christen","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0625","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000282067","article-title":"Mouse models for experimental autoimmune hepatitis: limits and chances","volume":"28","author":"Hardtke-Wolenski","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","article-title":"Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development","volume":"26","author":"Lapierre","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2010.05.019_bib0635","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/hep.23536","article-title":"Forkhead box p3(+) regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2010.05.019_bib0640","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000282068","article-title":"Cytochrome P450 2D6 as a model antigen","volume":"28","author":"Christen","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2010.05.019_bib0645","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.dld.2010.05.019_bib0650","article-title":"Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis","author":"Czaja A.J.","year":"2010","journal-title":"Dig Dis Sci"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865810002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:38:44Z","timestamp":1711600724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865810002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":130,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1590865810002070"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2010.05.019","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}